Product Code: PM4650
The global cystatin C assay market size is expected to reach USD 590.29 million by 2032, according to a new study by Polaris Market Research. The report "Cystatin C Assay Market Share, Size, Trends, Industry Analysis Report, By Product (Kits, Reagents, and Analyzers); By Sample Type; By Method; By Application; By End-user; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The growing prevalence of chronic kidney disease (CKD) and rising geriatric population are some of the major factors driving the growth of the cystatin C assay market. Lower kidney function can lead to various health problems, such as anemia, weak immunity, appetite loss, and low calcium levels. An increasing concern over these health problems is increasing the demand for cystatin C assays. Moreover, the high risk of CKD among patients with diabetes, hypertension, and heart diseases and the increasing prevalence and mortality rate of these diseases will positively impact the market growth in the coming years. For instance, according to the Centers for Disease Control & Prevention (CDC), in 2021, in the U.S., hypertension was a major cause of 691,095 deaths.
Cystatin C testing is gaining significant popularity due to its many advantages over creatinine testing. For instance, cystatin C is not affected by body mass or diet of an individual which makes it a reliable marker of kidney function. Moreover, the strong emphasis of the government to increase the expenditure on kidney-related diseases and the growing patient population suffering from kidney diseases are expected to propel the demand for cystatin C tests, thereby spurring market growth.
An increasing awareness related to the benefits of early screening of kidney disease will prove beneficial for the growth of the cystatin C assay market. Moreover, the accurate results and greater reliability of cystatin C tests in people with extreme obesity, liver cirrhosis, amputated limbs, and decreased muscle mass will increase its preference over the creatinine test. Furthermore, patients suffering from Glomerulonephritis are expected to increase the chances of end-stage kidney disease, thereby creating a demand for cystatin C assay. For instance, according to the U.S. Renal Data System (USRDS), in 2020, Glomerulonephritis held a 15.0% share among the major causes of end-stage kidney disease.
Cystatin C Assay Market Report Highlights
The kits segment dominated the market, as it serves the need for a comprehensive solution for carrying out the cystatin C assay.
The blood segment accounted for the largest share of the market, owing to the higher preference for blood samples by healthcare facilities and clinical laboratories.
The enzyme-linked immunosorbent assay (ELISA) segment held the largest market share, owing to factors such as simpler processes and easy availability of ELISA tests.
Diagnostics segment dominated the market, owing to an increasing demand for early screening tests for chronic kidney disease (CKD).
North America accounted for the largest market share, owing to the high burden of chronic kidney disease and sophisticated healthcare system.
The market players include Roche Diagnostics Limited, Siemens Healthineers AG, Abbott, Beckman Coulter, Inc., Thermo Fisher Scientific Inc., bioMerieux, S.A, and others.
Polaris Market Research has segmented the cystatin C assay market report based on product, sample type, method, application, end-user, and region:
Cystatin C Assay, Product Outlook (Revenue - USD Million, 2019 - 2032)
Cystatin C Assay, Sample Type Outlook (Revenue - USD Million, 2019 - 2032)
Cystatin C Assay, Method Outlook (Revenue - USD Million, 2019 - 2032)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Particle-Enhanced Turbidimetric Immunoassay (PETIA)
- Particle-Enhanced Nephelometric Immunoassay (PENIA)
- Chemiluminescent Immunoassay (CLIA)
- Immunofluorescence Assay
- Others
Cystatin C Assay, Application Outlook (Revenue - USD Million, 2019 - 2032)
Cystatin C Assay, End-user Outlook (Revenue - USD Million, 2019 - 2032)
- Hospitals
- Clinical Laboratories
- Pharmaceutical and Biotechnology Companies
- Others
Cystatin C Assay, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Australia
- Rest of APAC
- Latin America
- Argentina
- Brazil
- Mexico
- Rest of LA
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of MEA
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Cystatin C Assay Market Insights
- 4.1. Cystatin C Assay - Industry Snapshot
- 4.2. Cystatin C Assay Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing prevalence of chronic kidney diseases is expected to boost the cystatin C assay market growth
- 4.2.1.2. Several advantages associated with the use of cystatin C test over creatinine test will drive the market growth
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Cystatin C assay's high costs are predicted to impede the market expansion
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Cystatin C Assay Industry Trends
- 4.6. COVID-19 Impact Analysis
5. Global Cystatin C Assay Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 5.3. Kits
- 5.3.1. Global Cystatin C Assay Market, by Kits, by Region, 2019-2032 (USD Million)
- 5.4. Reagents
- 5.4.1. Global Cystatin C Assay Market, by Reagents, by Region, 2019-2032 (USD Million)
- 5.5. Analyzers
- 5.5.1. Global Cystatin C Assay Market, by Analyzers, by Region, 2019-2032 (USD Million)
6. Global Cystatin C Assay Market, by Method
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 6.3. Enzyme-Linked Immunosorbent Assay (ELISA)
- 6.3.1. Global Cystatin C Assay Market, by Enzyme-Linked Immunosorbent Assay (ELISA), by Region, 2019-2032 (USD Million)
- 6.4. Particle-Enhanced Turbidimetric Immunoassay (PETIA)
- 6.4.1. Global Cystatin C Assay Market, by Particle-Enhanced Turbidimetric Immunoassay (PETIA), by Region, 2019-2032 (USD Million)
- 6.5. Particle-Enhanced Nephelometric Immunoassay (PENIA)
- 6.5.1. Global Cystatin C Assay Market, by Particle-Enhanced Nephelometric Immunoassay (PENIA), by Region, 2019-2032 (USD Million)
- 6.6. Chemiluminescent Immunoassay (CLIA)
- 6.6.1. Global Cystatin C Assay Market, by Chemiluminescent Immunoassay (CLIA), by Region, 2019-2032 (USD Million)
- 6.7. Immunofluorescence Assay
- 6.7.1. Global Cystatin C Assay Market, by Immunofluorescence Assay, by Region, 2019-2032 (USD Million)
- 6.8. Others
- 6.8.1. Global Cystatin C Assay Market, by Others, by Region, 2019-2032 (USD Million)
7. Global Cystatin C Assay Market, by Sample Type
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 7.3. Blood
- 7.3.1. Global Cystatin C Assay Market, by Blood, by Region, 2019-2032 (USD Million)
- 7.4. Urine
- 7.4.1. Global Cystatin C Assay Market, by Urine, by Region, 2019-2032 (USD Million)
8. Global Cystatin C Assay Market, by Application
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 8.3. Diagnostics
- 8.3.1. Global Cystatin C Assay Market, by Diagnostics, by Region, 2019-2032 (USD Million)
- 8.4. Research
- 8.4.1. Global Cystatin C Assay Market, by Research, by Region, 2019-2032 (USD Million)
9. Global Cystatin C Assay Market, by End-user
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Global Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 9.3. Hospitals
- 9.3.1. Global Cystatin C Assay Market, by Hospitals, by Region, 2019-2032 (USD Million)
- 9.4. Clinical Laboratories
- 9.4.1. Global Cystatin C Assay Market, by Clinical Laboratories, by Region, 2019-2032 (USD Million)
- 9.5. Pharmaceutical and Biotechnology Companies
- 9.5.1. Global Cystatin C Assay Market, by Pharmaceutical and Biotechnology Companies, by Region, 2019-2032 (USD Million)
- 9.6. Others
- 9.6.1. Global Cystatin C Assay Market, by Others, by Region, 2019-2032 (USD Million)
10. Global Cystatin C Assay Market, by Geography
- 10.1. Key findings
- 10.2. Introduction
- 10.2.1. Cystatin C Assay Market Assessment, By Geography, 2019-2032 (USD Million)
- 10.3. Cystatin C Assay Market - North America
- 10.3.1. North America: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.3.2. North America: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.3.3. North America: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.3.4. North America: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.3.5. North America: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.3.6. Cystatin C Assay Market - U.S.
- 10.3.6.1. U.S.: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.3.6.2. U.S.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.3.6.3. U.S.: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.3.6.4. U.S.: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.3.6.5. U.S.: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.3.7. Cystatin C Assay Market - Canada
- 10.3.7.1. Canada: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.3.7.2. Canada.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.3.7.3. Canada: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.3.7.4. Canada: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.3.7.5. Canada: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.4. Cystatin C Assay Market - Europe
- 10.4.1. Europe: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.4.2. Europe.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.4.3. Europe: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.4.4. Europe: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.4.5. Europe: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.4.6. Cystatin C Assay Market - UK
- 10.4.6.1. UK: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.4.6.2. UK.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.4.6.3. UK: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.4.6.4. UK: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.4.6.5. UK: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.4.7. Cystatin C Assay Market - France
- 10.4.7.1. France: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.4.7.2. France.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.4.7.3. France: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.4.7.4. France: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.4.7.5. France: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.4.8. Cystatin C Assay Market - Germany
- 10.4.8.1. Germany: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.4.8.2. Germany.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.4.8.3. Germany: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.4.8.4. Germany: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.4.8.5. Germany: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.4.9. Cystatin C Assay Market - Italy
- 10.4.9.1. Italy: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.4.9.2. Italy.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.4.9.3. Italy: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.4.9.4. Italy: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.4.9.5. Italy: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.4.10. Cystatin C Assay Market - Spain
- 10.4.10.1. Spain: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.4.10.2. Spain.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.4.10.3. Spain: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.4.10.4. Spain: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.4.10.5. Spain: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.4.11. Cystatin C Assay Market - Netherlands
- 10.4.11.1. Netherlands: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.4.11.2. Netherlands.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.4.11.3. Netherlands: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.4.11.4. Netherlands: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.4.11.5. Netherlands: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.4.12. Cystatin C Assay Market - Russia
- 10.4.12.1. Russia: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.4.12.2. Russia.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.4.12.3. Russia: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.4.12.4. Russia: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.4.12.5. Russia: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.5. Cystatin C Assay Market - Asia Pacific
- 10.5.1. Asia Pacific: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.5.2. Asia Pacific.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.5.3. Asia Pacific: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.5.4. Asia Pacific: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.5.5. Asia Pacific: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.5.6. Cystatin C Assay Market - China
- 10.5.6.1. China: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.5.6.2. China.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.5.6.3. China: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.5.6.4. China: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.5.6.5. China: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.5.7. Cystatin C Assay Market - India
- 10.5.7.1. India: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.5.7.2. India.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.5.7.3. India: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.5.7.4. India: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.5.7.5. India: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.5.8. Cystatin C Assay Market - Japan
- 10.5.8.1. Japan: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.5.8.2. Japan.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.5.8.3. Japan: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.5.8.4. Japan: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.5.8.5. Japan: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.5.9. Cystatin C Assay Market - Malaysia
- 10.5.9.1. Malaysia: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.5.9.2. Malaysia.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.5.9.3. Malaysia: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.5.9.4. Malaysia: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.5.9.5. Malaysia: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.5.10. Cystatin C Assay Market - Indonesia
- 10.5.10.1. Indonesia: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.5.10.2. Indonesia.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.5.10.3. Indonesia: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.5.10.4. Indonesia: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.5.10.5. Indonesia: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.5.11. Cystatin C Assay Market - South Korea
- 10.5.11.1. South Korea: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.5.11.2. South Korea.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.5.11.3. South Korea: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.5.11.4. South Korea: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.5.11.5. South Korea: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.6. Cystatin C Assay Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.6.2. Middle East & Africa: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.6.3. Middle East & Africa: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.6.4. Middle East & Africa: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.6.5. Middle East & Africa: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.6.6. Cystatin C Assay Market - Saudi Arabia
- 10.6.6.1. Saudi Arabia: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.6.6.2. Saudi Arabia.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.6.6.3. Saudi Arabia: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.6.6.4. Saudi Arabia: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.6.6.5. Saudi Arabia: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.6.7. Cystatin C Assay Market - UAE
- 10.6.7.1. UAE: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.6.7.2. UAE.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.6.7.3. UAE: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.6.7.4. UAE: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.6.7.5. UAE: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.6.8. Cystatin C Assay Market - Israel
- 10.6.8.1. Israel: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.6.8.2. Israel.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.6.8.3. Israel: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.6.8.4. Israel: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.6.8.5. Israel: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.6.9. Cystatin C Assay Market - South Africa
- 10.6.9.1. South Africa: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.6.9.2. South Africa.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.6.9.3. South Africa: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.6.9.4. South Africa: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.6.9.5. South Africa: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.7. Cystatin C Assay Market - Latin America
- 10.7.1. Latin America: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.7.2. Latin America.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.7.3. Latin America: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.7.4. Latin America: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.7.5. Latin America: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.7.6. Cystatin C Assay Market - Mexico
- 10.7.6.1. Mexico: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.7.6.2. Mexico.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.7.6.3. Mexico: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.7.6.4. Mexico: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.7.6.5. Mexico: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.7.7. Cystatin C Assay Market - Brazil
- 10.7.7.1. Brazil: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.7.7.2. Brazil.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.7.7.3. Brazil: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.7.7.4. Brazil: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.7.7.5. Brazil: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
- 10.7.8. Cystatin C Assay Market - Argentina
- 10.7.8.1. Argentina: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
- 10.7.8.2. Argentina.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
- 10.7.8.3. Argentina: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
- 10.7.8.4. Argentina: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
- 10.7.8.5. Argentina: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
11. Competitive Landscape
- 11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
- 11.2. Partnerships/Collaborations/Agreements/Exhibitions
12. Company Profiles
- 12.1. Abbott (U.S.)
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
- 12.2. Abcam plc (UK)
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
- 12.3. Agilent Technologies, Inc (U.S.)
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
- 12.4. Beckman Coulter, Inc. (U.S.)
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
- 12.5. bioMerieux, S.A (France)
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
- 12.6. Bio-Rad Laboratories, Inc (U.S.)
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
- 12.7. Bio-Techne (U.S.)
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
- 12.8. DiaSys Diagnostic Systems GmbH (Germany)
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
- 12.9. Randox Laboratories Ltd. (UK)
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
- 12.10. Roche Diagnostics Limited (Switzerland)
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
- 12.11. Siemens Healthcare Private Limited (India)
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
- 12.12. Sino Biological, Inc. (China)
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Recent Development
- 12.13. Thermo Fisher Scientific Inc. (U.S.)
- 12.13.1. Company Overview
- 12.13.2. Financial Performance
- 12.13.3. Product Benchmarking
- 12.13.4. Recent Development